Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novo Nordisk and Boehringer Ingelheim describe new histamine H3 receptor modulators

April 24, 2003

New GSK-3 inhibitor with utility in diabetes therapy

April 24, 2003

Novo Nordisk and Fournier sign repaglinide comarketing deal for Europe

April 23, 2003

Pfizer patent covers novel thyroid receptor ligands and their use

April 23, 2003

Three series of IBAT inhibitors identified by AstraZeneca scientists

April 22, 2003

Novel glucose-lowering agents in Sankyo research pipeline

April 22, 2003

Atorvastatin reduces cardiovascular events in hypertensive patients with average cholesterol levels

April 22, 2003

Kaken presents new androgen receptor modulators

April 17, 2003

Non-TZD PPAR modulator with potentially improved biological responses

April 17, 2003

Axokine promotes weight loss in phase II study

April 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...